Carlyle's Claris Sells $194M Stake, Forms Injections JV
Carlyle Group LP-backed Claris Lifesciences Ltd. will sell 80 percent of its emerging-markets infusions business to a pair of Japanese companies for $194 million, forming a three-way joint venture to ramp...To view the full article, register now.
Already a subscriber? Click here to view full article